REYATAZ 300 mg/1

REYATAZ 300 mg capsules are an antiretroviral medication used to manage HIV infection. This gelatin-coated oral treatment is designed to support HIV management regimens.

REYATAZ 300 mg capsules are primarily used as part of a combination therapy to manage HIV infection. This medication works by inhibiting protease, an enzyme crucial for viral replication. Healthcare providers often prescribe it alongside other antiretroviral drugs to reduce viral load and improve immune function. REYATAZ is not a cure for HIV but helps control the virus, reducing the risk of disease progression.

Common effects of REYATAZ 300 mg capsules may include nausea, vomiting, and stomach pain. Some users experience changes in body fat distribution, such as increased waist size or loss of limb fat. Skin discoloration or rash can also occur. These effects vary among individuals and are not exhaustive; consult a healthcare provider for personalized advice.

REYATAZ 300 mg capsules should be handled with care, stored at room temperature, and kept away from moisture and heat. This medication may interact with other drugs, so it's important to inform your healthcare provider about all medications you are taking. Pregnant or breastfeeding individuals should discuss potential risks with their healthcare provider before use.

REYATAZ 300 mg capsules can interact with various medications, including other antiretrovirals, statins, and certain antibiotics. Alcohol and other substances that induce liver enzymes may affect the efficacy of REYATAZ. Always consult a healthcare provider before combining REYATAZ with other treatments to avoid adverse interactions.